Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
Current Opinion in Immunology
|
April 1, 1989
Origins of autoantibodies
A Marshak-Rothstein
Current Directions in Autoimmunity
|
January 17, 2002
Fas and Fas ligand in autoimmunity
I R Rifkin, A Marshak-Rothstein
Journal of Leukocyte Biology
|
June 2, 2011
Editorial: Interfering with B cell immunity
J E Harris, A Marshak-Rothstein
European Journal of Immunology
|
September 1, 1990
Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages
R M Glaser, A Marshak-Rothstein
Current Opinion in Immunology
|
December 1, 1996
B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men
K B Elkon, A Marshak-Rothstein
European Journal of Immunology
|
December 18, 2001
Sp1 is the major fasl gene activator in abnormal CD4(-)CD8(-)B220(+) T cells of lpr and gld mice
S Xiao, A Marshak-Rothstein, S T Ju
The Journal of Experimental Medicine
|
April 5, 2000
Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival
A M Hohlbaum, S Moe, A Marshak-Rothstein
Hybridoma
|
January 1, 1985
A rapid method for comparing monoclonal antibodies by limited proteolysis and electrophoresis
D Weissman, T L Rothstein, A Marshak-Rothstein
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1987
The lpr gene is associated with resistance to engraftment by lymphoid but not erythroid stem cells from normal mice
D L Perkins, J Michaelson, A Marshak-Rothstein
The Journal of Biological Chemistry
|
September 3, 1999
Characterization of a novel cis-element that regulates Fas ligand expression in corneal endothelial cells
J Zhang, B Ma, A Marshak-Rothstein, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
Current Opinion in Immunology
|
April 1, 1989
Origins of autoantibodies
A Marshak-Rothstein
Current Directions in Autoimmunity
|
January 17, 2002
Fas and Fas ligand in autoimmunity
I R Rifkin, A Marshak-Rothstein
Journal of Leukocyte Biology
|
June 2, 2011
Editorial: Interfering with B cell immunity
J E Harris, A Marshak-Rothstein
European Journal of Immunology
|
September 1, 1990
Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages
R M Glaser, A Marshak-Rothstein
Current Opinion in Immunology
|
December 1, 1996
B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men
K B Elkon, A Marshak-Rothstein
European Journal of Immunology
|
December 18, 2001
Sp1 is the major fasl gene activator in abnormal CD4(-)CD8(-)B220(+) T cells of lpr and gld mice
S Xiao, A Marshak-Rothstein, S T Ju
The Journal of Experimental Medicine
|
April 5, 2000
Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival
A M Hohlbaum, S Moe, A Marshak-Rothstein
Hybridoma
|
January 1, 1985
A rapid method for comparing monoclonal antibodies by limited proteolysis and electrophoresis
D Weissman, T L Rothstein, A Marshak-Rothstein
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1987
The lpr gene is associated with resistance to engraftment by lymphoid but not erythroid stem cells from normal mice
D L Perkins, J Michaelson, A Marshak-Rothstein
The Journal of Biological Chemistry
|
September 3, 1999
Characterization of a novel cis-element that regulates Fas ligand expression in corneal endothelial cells
J Zhang, B Ma, A Marshak-Rothstein, et al.
Page
of 9